Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
45
datasets available to search
ShareScore release 0.9.0
Dataset results
45 results for “randomized cross-over study”
A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants
ClinicalTrials.gov study NCT03319953. IPD Sharing: YES. Countries: 1. Publications: 1.
Randomized Cross-Over Study of Self-Insertion of Two Placebo Vaginal Film Formulations
ClinicalTrials.gov study NCT04391036. IPD Sharing: NO. Countries: 1. Publications: 3.
Randomized, Double-blind, Placebo-controlled, Multicenter, Cross-over Study to Assess the Effects of a 3 Week Therapy Each With QVA149 Versus Placebo on Pulmonary Function and Average Physical Activit
ClinicalTrials.gov study NCT01996319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cysti
ClinicalTrials.gov study NCT02137382. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Supplementary material for: Neural effects of oxytocin and mimicry in frontotemporal dementia: A randomized cross-over study
<p><span>OBJECTIVE: Reduced empathy is one of the hallmark and untreatable symptoms of frontotemporal dementia (FTD). The objective of this study was to determine whether intranasal oxytocin, alone or in combination with instructed mimicry of facial expressions, would augment neural activity in patients with FTD in brain regions associated with empathy, emotion processing and the simulation network, as indexed by blood-oxygen-level dependent (BOLD) signal during functional magnetic resonance imaging (fMRI).</span></p> <p><span>METHODS: In a placebo-controlled, randomized cross-over design, 28 patients with FTD received 72 IU of intranasal oxytocin or placebo and then completed a fMRI facial expression mimicry task. </span></p> <p><span>RESULTS: Oxytocin alone, and in combination with instructed mimicry, increased activity in regions of the simulation network and in limbic regions associated with emotional expression processing. </span></p> <p><span>CONCLUSIONS: The findings demonstrate latent capacity to augment neural activity in affected limbic and other frontal and temporal regions during social cognition in patients with FTD, and support the promise and need for further investigation of these interventions as therapeutics in FTD.</span></p> <p><span><a>CLASSIFICATION OF EVIDENCE:</a> This study provides Class III evidence that a single dose of 72 IU intranasal oxytocin augments BOLD signal in patients with FTD during viewing of emotional facial expressions.</span></p>
The Hemodynamics Effect of Glibenclamide on Levcromakalim Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study Wi
ClinicalTrials.gov study NCT03886922. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study
ClinicalTrials.gov study NCT02794662. IPD Sharing: NO. Countries: 1. Publications: 1.
A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of DIC075V on QTc Intervals in Healthy Subjects
ClinicalTrials.gov study NCT01812538. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phenytoin and Driving Safety: A Randomized, Controlled Cross-Over Study
ClinicalTrials.gov study NCT00581893. IPD Sharing: NO. Countries: 1. Publications: 0.
A Multi-center Randomized Control Cross-over Study to Evaluate the Safety and Effectiveness of the Dayspring Active Wearable Compression Device vs. an Advanced Pneumatic Compression Device for Treatin
ClinicalTrials.gov study NCT04908254. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase I, Randomized, Single-Blind, Four-Period Cross-Over, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of GR181413A/AT1001 in Healthy J
ClinicalTrials.gov study NCT01853852. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Loperamide vs. Placebo's Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study
ClinicalTrials.gov study NCT02266849. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations
ClinicalTrials.gov study NCT02070796. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Supplementary material for: Neural effects of oxytocin and mimicry in frontotemporal dementia: A randomized cross-over study
Open the record for dataset details and reuse information.
A Randomized Cross-over Study for Normal Pressure Hydrocephalus
ClinicalTrials.gov study NCT01798641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflo
ClinicalTrials.gov study NCT06983054. IPD Sharing: UNDECIDED. Countries: 2. Publications: 0.
"Effects of Oral Citrulline on Protein Metabolism in Healthy Humans: a Prospective, Randomized, Double-blind , Cross-over Study" (Citrugrêle)
ClinicalTrials.gov study NCT00756080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Randomized, Cross-Over Study to Investigate the Efficacy and Safety of Mexiletine PR Compared to Mexiletine IR
ClinicalTrials.gov study NCT07097701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic Hyperkalemia
ClinicalTrials.gov study NCT05535920. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)
ClinicalTrials.gov study NCT00240929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.